MELOCAM (MELOXICAM)

Anti-inflammatory and Analgesic Medicine — Injection and Suppositories

Melocam contains meloxicam, a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation associated with certain musculoskeletal and inflammatory joint conditions. It reduces the production of prostaglandins, which contribute to pain, swelling, and inflammation.

1. MELOCAM 15 MG/2 ML — 3 AMPOULES

• Acute inflammatory joint symptoms: Helps relieve pain and inflammation during acute exacerbations of rheumatoid arthritis.
• Ankylosing spondylitis: May help reduce pain and stiffness during acute inflammatory episodes.
• Short-term pain relief: Provides an alternative route when oral administration is not possible or appropriate.

The exact approved indications depend on the specific product's official leaflet.

Recommended Use and Dosage

• Administration: Intramuscular injection only for products labeled for this route.
• The injection must be administered by a qualified healthcare professional.
• The usual adult dose is 15 mg once daily; the dose may be reduced to 7.5 mg in patients at increased risk of adverse effects.
• Injectable treatment is generally limited to one initial injection. In exceptional circumstances, when oral treatment is unsuitable, it may be continued for no more than 2–3 days, according to the applicable product information.
• The total daily dose from all meloxicam formulations must not exceed 15 mg.

2. MELOCAM 15 MG — 5 SUPPOSITORIES

• Helps relieve pain and inflammation associated with inflammatory joint conditions.
• May reduce joint stiffness, swelling, and tenderness associated with osteoarthritis and rheumatoid arthritis.
• Provides an alternative route of administration when oral medication is unsuitable, if prescribed for this purpose.

Recommended Use and Dosage

• Use only as prescribed by a physician and according to the product leaflet.
• Suppositories are administered rectally.
• The total meloxicam dose from all formulations combined must not exceed 15 mg per day in adults.
• Do not combine with other meloxicam products or other NSAIDs unless specifically directed by a healthcare professional.

Warnings and Precautions

The following precautions apply to both formulations:

• Gastrointestinal risks: May cause stomach ulcers, gastrointestinal bleeding, or perforation.
• Cardiovascular risks: May increase the risk of heart attack, stroke, fluid retention, and worsening hypertension.
• Kidney impairment: Use requires medical assessment, particularly in patients with kidney disease or dehydration.
• Allergy: Avoid in patients with a history of asthma, urticaria, or allergic reactions triggered by meloxicam, aspirin, or other NSAIDs.
• Drug interactions: Consult a healthcare professional before combining with anticoagulants, antiplatelet agents, corticosteroids, other NSAIDs, diuretics, or certain blood pressure medicines.
• Pregnancy: Avoid unless specifically advised by a physician. NSAIDs should generally be avoided from 20 weeks of pregnancy onward unless necessary under medical supervision, and avoided around 30 weeks and later under U.S. prescribing guidance.
• Older adults: May have a higher risk of gastrointestinal bleeding and kidney-related adverse effects.

Seek urgent medical attention for vomiting blood, black stools, chest pain, difficulty breathing, severe allergic reactions, or markedly reduced urine output.

Storage

Store according to the manufacturer's instructions. Protect ampoules from light where specified, and keep both formulations out of reach of children. Do not use after the expiry date.

Patient Disclaimer

This information is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Melocam is an NSAID that may cause serious gastrointestinal, cardiovascular, and kidney-related adverse effects. Use only under the supervision of a qualified healthcare professional. Injectable meloxicam must be administered by a healthcare professional, and suppositories must be used according to the product leaflet. Do not combine formulations or exceed the prescribed dose.

References

1. French Public Medicines Database, ANSM (.gouv.fr) — Mobic 15 mg/1.5 mL Injection: Official Product Information.
2. South African Health Products Regulatory Authority (.org.za) — Mobic Injection: Patient Information Leaflet.
3. U.S. National Library of Medicine, DailyMed (.gov) — Meloxicam Prescribing Information.